Back to Search
Start Over
Aberrant super-enhancer landscape reveals core transcriptional regulatory circuitry in lung adenocarcinoma
- Source :
- Oncogenesis, Oncogenesis, Vol 9, Iss 10, Pp 1-12 (2020)
- Publication Year :
- 2020
- Publisher :
- Springer Science and Business Media LLC, 2020.
-
Abstract
- Lung adenocarcinoma (LUAD) relies on dysregulated gene expression to sustain its infinite growth and progression. Emerging evidence indicates that aberrant transcriptional program results from core transcriptional regulatory circuitry (CRC) which is driven by super-enhancers (SEs). In this study, by integrating profiles of H3K27Ac chromatin immunoprecipitation sequencing (ChIP-seq) from normal adult lung and LUAD cell lines, we revealed that widespread alterations of the super-enhancer were presence during lung carcinogenesis. With SE-based modeling of regulatory circuits and assessments of transcription factor (TF) dependencies, we reconstructed an interconnected transcriptional regulation network formed by three master TFs, including ELF3, EHF, and TGIF1, all of which promoted each other’s expression that confirmed by ChIP-qPCR and western blot. Loss-of function assay revealed that each of them is essential for LUAD cells survival, invasion and metastasis. Meanwhile, the rescue assay also illustrated the transacting transcriptional regulatory circuitry. In addition, the mRNA levels of ELF3, EHF, and TGIF1 were differentially expressed in LUAD tumors and peritumoral tissue. IHC of serial sections revealed that high expressions of CRC (ELF3/EHF/TGIF1-High) were closely associated with high proliferative activity in tumor tissue and poor prognosis on patients with LUAD. Finally, we used small molecular inhibitors to perturb the transcriptional circuitry, also exhibited a prominent anti-cancer effect in vitro. Our findings reveal the mechanism of the transcriptional dysregulation and addiction of LUAD.
- Subjects :
- 0301 basic medicine
Cancer Research
Oncogenes
Biology
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
medicine.disease_cause
medicine.disease
lcsh:RC254-282
Article
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Super-enhancer
Cell culture
030220 oncology & carcinogenesis
Gene expression
medicine
Cancer research
Transcriptional regulation
Immunohistochemistry
Adenocarcinoma
Carcinogenesis
Non-small-cell lung cancer
Molecular Biology
Transcription factor
Subjects
Details
- ISSN :
- 21579024
- Volume :
- 9
- Database :
- OpenAIRE
- Journal :
- Oncogenesis
- Accession number :
- edsair.doi.dedup.....5ce0e1931b6413fc080783559c0d398d
- Full Text :
- https://doi.org/10.1038/s41389-020-00277-9